PROTAC ERRα Degrader-2

• UNSPSC Description:

  PROTAC ERRα Degrader-2 comprises a MDM2 ligand binding group, a linker and an estrogen-related receptor alpha (ERRa) binding group. PROTAC ERRα Degrader-2 is an estrogen-related receptor alpha (ERRa) degrader[1].

• Target Antigen:

  Estrogen Receptor/ERR; PROTACs

• Type:

  Reference compound

• Related Pathways:

  PROTAC;Vitamin D Related/Nuclear Receptor

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/protac-erralpha-degrader-2.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(N1[C@H]([C@H](N=C1C2=C(OC(C)C)C=C(C=C2)OC)C3=CC=C(C=C3)Cl)C4=CC=C(C=C4)Cl)N5CC(N(CC5)CC(NCCCCCNC(/C(C#N)=C/C6=CC(OC)=C(C=C6)OCC7=C(C(F)(F)F)C=C(C=C7)C(F)(F)F)=O)=O)=O

• Molecular Weight:

  1150.99

• References & Citations:

  [1]Peng L, et al. Identification of New Small-Molecule Inducers of Estrogen-related Receptor α (ERRα) Degradation. ACS Med Chem Lett. 2019 Apr 12;10(5):767-772.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2306388-85-0